Clinical Trial: Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07198373) titled 'Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma' on Sept. 15.

Brief Summary: This study is a single-center, Phase IV clinical trial designed to collect and analyze data on the efficacy and safety of zanubrutinib as maintenance therapy following CAR-T cell therapy in subjects with non-Hodgkin B-cell lymphoma.

Study Start Date: Sept. 20

Study Type: OBSERVATIONAL

Condition: B Cell Lymphoma

Intervention: DRUG: Maintenance Therapy Group

Patients achieving remission (complete or partial) at the 3-month post-CAR-T infusion assessment recei...